Kel Little

Kel Little is an accomplished Executive Business Director in Oncology Account Management at Daiichi Sankyo, Inc., with over 15 years of experience in the pharmaceutical industry. Starting in December 2007, Kel has successfully led the annual access and reimbursement strategies for a $1B+ Oncology Business Unit, managing a team of 4 direct and 24 indirect reports. Prior roles include National Director of GPO Alliances, where Kel built a team and fostered relationships with C-Suite executives, and Director of Southeast Oncology Account Management, achieving significant sales growth across multiple states. Previous experience includes various management positions at GSK and a foundational career at Precision Fabrics Group. Kel holds a Bachelor of Science degree from North Carolina State University and has further education from the Joseph M Bryan School of Business & Economics at the University of North Carolina, Greensboro.